Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism.

The inflammatory protein Pentraxin 3 in cardiovascular disease. Immun Ageing (2016) 0.75

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J (2012) 16.00

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med (2004) 5.68

Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol (2013) 4.89

Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol (2010) 2.60

PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation (2000) 2.19

Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism. Intern Emerg Med (2009) 2.05

Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg (2002) 1.96

Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol (2013) 1.92

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92

Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol (2006) 1.72

Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg (2011) 1.66

Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients. Eur Respir J (2014) 1.50

Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension. Eur Respir J (2008) 1.46

Improved survival in medically treated chronic thromboembolic pulmonary hypertension. Circ J (2013) 1.43

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med (2009) 1.43

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum (2001) 1.37

C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 1.34

Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J (2012) 1.31

Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood (2004) 1.25

Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol (2002) 1.24

Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc (2006) 1.22

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res (2001) 1.14

Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med (2011) 1.12

Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Ann Thorac Surg (2007) 1.11

PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis. Cardiovasc Pathol (2010) 1.09

Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome. PLoS One (2013) 1.08

Assessment of operability in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc (2006) 1.04

The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum (2008) 1.01

The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Ann N Y Acad Sci (2013) 1.00

Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics. Circ J (2007) 0.99

Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity (2011) 0.99

Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension. PLoS One (2012) 0.95

Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia. Clin Chem Lab Med (2013) 0.85

Pentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study. Pulm Circ (2014) 0.83

The role of pentraxin 3 as diagnostic value in classification of patients with heart failure. Clin Biochem (2013) 0.82